Home > Research > Publications & Outputs > Should the 14‐day rule for embryo research beco...

Electronic data

Links

Text available via DOI:

View graph of relations

Should the 14‐day rule for embryo research become the 28‐day rule?

Research output: Contribution to Journal/MagazineEditorial

Published

Standard

Should the 14‐day rule for embryo research become the 28‐day rule? / Appleby, John B; Bredenoord, Annelien L.
In: EMBO Molecular Medicine, 07.08.2018.

Research output: Contribution to Journal/MagazineEditorial

Harvard

APA

Vancouver

Appleby JB, Bredenoord AL. Should the 14‐day rule for embryo research become the 28‐day rule? EMBO Molecular Medicine. 2018 Aug 7. doi: 10.15252/emmm.201809437

Author

Appleby, John B ; Bredenoord, Annelien L. / Should the 14‐day rule for embryo research become the 28‐day rule?. In: EMBO Molecular Medicine. 2018.

Bibtex

@article{2beaafe7663349deb3cd198d5a90a100,
title = "Should the 14‐day rule for embryo research become the 28‐day rule?",
abstract = "The “14‐day rule”—broadly construed—is used in science policy and regulation to limit research on human embryos to a maximum period of 14 days after their creation or to the equivalent stage of development that is normally attributed to a 14‐day‐old embryo (Hyun et al, 2016; Nuffield Council on Bioethics, 2017). For several decades, the 14‐day rule has been a shining example of how science policy and regulation can be developed with interdisciplinary consensus and applied across a number of countries to help fulfil an ethical and practical purpose: to facilitate efficient and ethical embryo research. However, advances in embryology and biomedical research have led to suggestions that the 14‐day rule is no longer adequate (Deglincerti et al, 2016; Shahbazi et al, 2016; Hurlbut et al, 2017). Therefore, should the 14‐day rule be extended and, if so, where should we draw a new line for permissible embryo research? Here, we provide scientific, regulatory and ethical arguments that the 14‐day rule should be extended to 28 days (or the developmental equivalent stage of a 28‐day‐old embryo).",
keywords = "synthetic embryo, stem cell derived gamete, Organoids, ethics, regulation, 14-day rule, HFEA , SHEEF",
author = "Appleby, {John B} and Bredenoord, {Annelien L}",
year = "2018",
month = aug,
day = "7",
doi = "10.15252/emmm.201809437",
language = "English",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Should the 14‐day rule for embryo research become the 28‐day rule?

AU - Appleby, John B

AU - Bredenoord, Annelien L

PY - 2018/8/7

Y1 - 2018/8/7

N2 - The “14‐day rule”—broadly construed—is used in science policy and regulation to limit research on human embryos to a maximum period of 14 days after their creation or to the equivalent stage of development that is normally attributed to a 14‐day‐old embryo (Hyun et al, 2016; Nuffield Council on Bioethics, 2017). For several decades, the 14‐day rule has been a shining example of how science policy and regulation can be developed with interdisciplinary consensus and applied across a number of countries to help fulfil an ethical and practical purpose: to facilitate efficient and ethical embryo research. However, advances in embryology and biomedical research have led to suggestions that the 14‐day rule is no longer adequate (Deglincerti et al, 2016; Shahbazi et al, 2016; Hurlbut et al, 2017). Therefore, should the 14‐day rule be extended and, if so, where should we draw a new line for permissible embryo research? Here, we provide scientific, regulatory and ethical arguments that the 14‐day rule should be extended to 28 days (or the developmental equivalent stage of a 28‐day‐old embryo).

AB - The “14‐day rule”—broadly construed—is used in science policy and regulation to limit research on human embryos to a maximum period of 14 days after their creation or to the equivalent stage of development that is normally attributed to a 14‐day‐old embryo (Hyun et al, 2016; Nuffield Council on Bioethics, 2017). For several decades, the 14‐day rule has been a shining example of how science policy and regulation can be developed with interdisciplinary consensus and applied across a number of countries to help fulfil an ethical and practical purpose: to facilitate efficient and ethical embryo research. However, advances in embryology and biomedical research have led to suggestions that the 14‐day rule is no longer adequate (Deglincerti et al, 2016; Shahbazi et al, 2016; Hurlbut et al, 2017). Therefore, should the 14‐day rule be extended and, if so, where should we draw a new line for permissible embryo research? Here, we provide scientific, regulatory and ethical arguments that the 14‐day rule should be extended to 28 days (or the developmental equivalent stage of a 28‐day‐old embryo).

KW - synthetic embryo

KW - stem cell derived gamete

KW - Organoids

KW - ethics

KW - regulation

KW - 14-day rule

KW - HFEA

KW - SHEEF

U2 - 10.15252/emmm.201809437

DO - 10.15252/emmm.201809437

M3 - Editorial

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

ER -